Rexahn Pharmaceuticals Expands its Intellectual Property Around Class of Potent Anti-cancer Isoquinolinamine Compounds Dec 17, 2012
Rexahn Pharmaceuticals Granted European Patent for Novel Anti-cancer Isoquinolinamine Compounds Sep 26, 2012
Rexahn Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference Sep 6, 2012